Combination therapy with type I and type II anti-CD20 antibodies

Details for Australian Patent Application No. 2008295140 (hide)

Owner F. Hoffmann-La Roche AG Roche Glycart AG

Inventors Friess, Thomas; Umana, Pablo; Klein, Christian

Agent Davies Collison Cave

Pub. Number AU-A-2008295140

PCT Pub. Number WO2009/030368

Priority 07017337.2 05.09.07 EP

Filing date 20 August 2008

Wipo publication date 12 March 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

18 March 2010 PCT application entered the National Phase

  PCT publication WO2009/030368 Priority application(s): WO2009/030368

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008295143-Handling claw

2008295108-Packaging component and process for producing it